Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events
Abstract Genotype-informed anticancer therapies such as BRAF inhibitors can show remarkable clinical efficacy in BRAF-mutant melanoma; however, drug resistance poses a major hurdle to successful cancer treatment. Many resistance events to targeted therapies have been identified, suggesting a complex...
Saved in:
Main Authors: | Li Chen, Iulian Pruteanu-Malinici, Anahita Dastur, Xunqin Yin, Dennie Frederick, Ruslan I. Sadreyev, Cyril H. Benes |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-86694-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of Hippo-YAP1/TAZ pathway in metabolic dysfunction-associated steatotic liver disease
by: Wei Xuan, et al.
Published: (2025-01-01) -
Exploring the Revolutionary Impact of YAP Pathways on Physical and Rehabilitation Medicine
by: Carmelo Pirri
Published: (2025-01-01) -
Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression
by: Du Jiamin, et al.
Published: (2022-09-01) -
YAP/TAZ-associated cell signaling – at the crossroads of cancer and neurodevelopmental disorders
by: Aderonke O. Ajongbolo, et al.
Published: (2025-01-01) -
Cannabidiol Ameliorates Doxorubicin-Induced Myocardial Injury via Activating Hippo Pathway
by: Dong T, et al.
Published: (2025-01-01)